Castle Biosciences, Inc. (CSTL)

NASDAQ: CSTL · Real-Time Price · USD

32.52

-1.68 (-4.91%)

At close: Nov 6, 2026, 4:00 PM EST

32.68

+0.16 (0.48%)

After-hours: Nov 6, 2026, 7:59 PM EST

Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,002	1,135	746	581	620	1,103
Market Cap Growth	2.28%	52.12%	28.53%	-6.38%	-43.76%	-32.00%
Enterprise Value	761	885	493	366	368	740
Last Close Price	32.52	38.90	26.65	21.58	23.54	42.87

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	40.91	-	-	-
PS Ratio	2.66	3.30	2.25	2.64	4.53	11.72
PB Ratio	2.09	2.41	1.64	1.48	1.55	2.68
P/TBV Ratio	2.59	3.06	2.13	2.12	2.27	3.42
P/FCF Ratio	252.89	40.09	20.43	-	-	-
P/OCF Ratio	25.22	17.65	11.51	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.02	2.57	1.49	1.66	2.69	7.86
EV/EBITDA Ratio	-	-	20.00	-	-	-
EV/EBIT Ratio	-	-	56.90	-	-	-
EV/FCF Ratio	192.06	31.25	13.50	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.08	0.08	0.06	0.04	0.03	0.02
Debt / EBITDA Ratio	-	18.82	0.96	-	-	-
Debt / FCF Ratio	9.23	1.31	0.72	-	-	-
Net Debt / Equity Ratio	-0.50	-0.56	-0.58	-0.58	-0.61	-0.78
Net Debt / EBITDA Ratio	19.96	128.74	-10.81	4.09	3.04	8.76
Net Debt / FCF Ratio	-60.83	-9.27	-7.30	11.83	5.18	14.30
Asset Turnover	0.66	0.62	0.68	0.49	0.30	0.21
Inventory Turnover	9.09	7.73	7.49	7.55	10.67	7.47
Quick Ratio	4.90	5.01	6.98	5.90	7.81	13.94
Current Ratio	5.28	5.26	7.29	6.20	8.09	14.22
Return on Equity (ROE)	-4.87%	-5.21%	4.31%	-14.54%	-16.56%	-7.56%
Return on Assets (ROA)	-3.07%	-2.56%	1.10%	-9.43%	-12.52%	-5.56%
Return on Invested Capital (ROIC)	-11.75%	-11.43%	4.16%	-42.80%	-74.56%	-44.33%
Return on Capital Employed (ROCE)	-5.50%	-4.50%	1.80%	-16.80%	-22.20%	-9.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.37%	-2.13%	2.44%	-9.89%	-10.82%	-2.84%
FCF Yield	0.40%	2.50%	4.90%	-3.31%	-7.62%	-2.04%
Buyback Yield / Dilution	-4.31%	0.92%	-9.15%	-2.87%	-3.65%	-32.80%

SEC Filings: 10-K · 10-Q